# Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot Study

> **NCT06022406** · PHASE2 · COMPLETED · sponsor: **Jean-Pierre Routy** · enrollment: 20 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **BIOLOGICAL:** FMT capsules
- **BIOLOGICAL:** Placebo capsules

## Key facts

- **NCT ID:** NCT06022406
- **Lead sponsor:** Jean-Pierre Routy
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-31
- **Primary completion:** 2025-08-13
- **Final completion:** 2025-08-13
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06022406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06022406, "Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot Study". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06022406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*